FIGS Announces Pricing of Upsized Initial Public Offering
FIGS, Inc. announced the pricing of its upsized initial public offering, offering 26,386,363 shares at $22.00 per share. The offering includes 4,636,364 shares from FIGS and 21,749,999 shares from Tulco, LLC, its largest stockholder, with underwriters having a 30-day option for 3,957,954 additional shares. Trading on the NYSE is expected to start on May 27, 2021, under the ticker symbol FIGS. The closing is anticipated on June 1, 2021, subject to customary conditions.
- Upsized offering signals strong investor demand.
- Funds raised could support growth initiatives and operations.
- No proceeds for FIGS from Tulco's share sale may limit immediate capital infusion.
- Dilution risk for existing shareholders due to large stock offerings.
FIGS, Inc. (FIGS), a direct-to-consumer healthcare apparel and lifestyle brand founded by Heather Hasson and Trina Spear, today announced the pricing of its upsized initial public offering of 26,386,363 shares of its Class A common stock at a price to the public of
Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, Barclays Capital Inc. and Credit Suisse Securities (USA) LLC are acting as lead book-running managers for the offering. BofA Securities, Inc. is acting as a book-running manager for the offering. KeyBanc Capital Markets Inc., Piper Sandler & Co., Oppenheimer & Co. Inc., Guggenheim Securities, LLC, Cowen and Company, LLC, Telsey Advisory Group LLC, Samuel A. Ramirez & Company, Inc., Academy Securities, Inc., R. Seelaus & Co., LLC and Siebert Williams Shank & Co., LLC are acting as co-managers for the offering.
The offering is being made only by means of a prospectus. A copy of the final prospectus, when available, may be obtained from: Goldman Sachs & Co. LLC, 200 West Street, New York, New York 10282, Attn: Prospectus Department, Telephone: (866) 471-2526, Email: prospectus-ny@ny.email.gs.com; Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, New York 10014, Attn: Prospectus Department; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue Edgewood, New York 11717, Telephone: (888) 603-5847, Email: Barclaysprospectus@broadridge.com; and Credit Suisse Securities (USA) LLC, Attn: Credit Suisse Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, Telephone: (800) 221-1037, Email: usa.prospectus@credit-suisse.com.
A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission on May 26, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About FIGS
FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals. We create technically advanced apparel and products for healthcare professionals that feature an unmatched combination of comfort, durability, function and style. We market and sell our products directly through our digital platform to provide a seamless experience for healthcare professionals.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210526006179/en/
FAQ
What is the offering price for FIGS shares?
How many shares of FIGS are being offered?
What date is FIGS expected to begin trading?
Who is the largest stockholder offering shares in the IPO?